Thermo Fisher Scientific returns 14.21% annually over 15 years

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Thermo Fisher Scientific outperformed the market with a 14.21% average annual return over the last 15 years. A $100 investment in the company 15 years ago would have grown to $743.26, highlighting the power of compounded returns.

powered bylight_fuzz_icon
43424644

*this image is generated using AI for illustrative purposes only.

Thermo Fisher Scientific has outperformed the market over the past 15 years by 1.73% on an annualized basis, producing an average annual return of 14.21%. The company currently holds a market capitalization of $174.33 billion.

Investment Growth

If an investor had bought $100 of Thermo Fisher Scientific stock 15 years ago, it would be worth $743.26 today based on a price of $462.10 at the time of writing.

Performance Metrics

The following table outlines the key performance figures for Thermo Fisher Scientific over the last 15 years:

Metric Value
Average Annual Return 14.21%
Market Outperformance 1.73%
Current Share Price $462.10
Market Capitalization $174.33 billion
Growth of $100 Investment $743.26

The key insight from this data is the significant impact compounded returns can have on cash growth over an extended period.

Can Thermo Fisher Scientific maintain its 14.21% average annual return over the next decade given current market conditions?

How might recent acquisitions or R&D investments impact the company's future growth trajectory?

What are the potential risks to Thermo Fisher's market outperformance in the evolving healthcare and biotech sectors?

like20
dislike

Piper Sandler initiates coverage on Thermo Fisher with Neutral rating

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Piper Sandler analyst David Westenberg initiates coverage on Thermo Fisher Scientific with a Neutral rating and a price target of $510.

powered bylight_fuzz_icon
42722562

*this image is generated using AI for illustrative purposes only.

Piper Sandler analyst David Westenberg has initiated coverage on Thermo Fisher Scientific with a Neutral rating and a price target of $510. The rating provides a benchmark for the stock's performance potential relative to its current trading levels.

Coverage Details

The initiation by Piper Sandler offers investors a new perspective on Thermo Fisher Scientific's market position. The Neutral rating suggests that the stock is expected to perform in line with the broader market or industry averages over the specified period.

Analyst Firm Rating Price Target
David Westenberg Piper Sandler Neutral $510

The price target of $510 serves as a key indicator of the firm's valuation expectations for the company. Investors will likely monitor the stock's movement relative to this target in the coming sessions.

What factors could drive Thermo Fisher Scientific to outperform the Neutral rating?

How might recent market trends impact the company's ability to reach the $510 price target?

What are the key risks Piper Sandler identified that could limit upside potential?

like15
dislike